Skip to content
MARKETS / NASDAQ / POCI
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

Precision Optics Corporation, Inc. POCI

15 fiscal years on record · USD · FY2024 reported · SEC filings only
$19.1M
▼ 0.1% YoY
$-5.8M
$-3.8M
In brief

What this company does

We have been a developer and manufacturer of advanced optical instruments since 1982, and we operate primarily in two key market segments: medical devices and advanced defense/aerospace products. We design and manufacture ultra-high precision endoscopes and very small Microprecision lenses, assemblies and complete medical devices to meet the surgical community’s continuing demand for smaller, disposable, and more enhanced imaging systems for minimally invasive surgery. We also apply our unique technologies to applications in the Defense / Aerospace markets including applications supporting satellite network communications. Effective June 1, 2019, we acquired the operating assets of Ross Optical Industries, Inc. of El Paso, Texas. Effective October 1, 2021, we acquired the operating assets of Lighthouse Imaging, LLC of Windham, Maine,which expanded our electrical engineering capabilities in the development of end-to-end medical visualization devices. As of June 30, 2025, we had 90 employees, all of which were full-time employees.

Written from the business description in Precision Optics Corporation, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 29 September 2025. Every sentence was checked against that document before publication.

Growth
USD 19.1M
Revenue, FY2024 · full 15-year series below
Revenue $M Net income $M
FY2024 · Revenue 19.1 · Net income -5.8
8M16M-2M-4M20102012201420162018202020222024
Compound annual growth
+6.8%
+14.0%
+17.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +14.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−30 cents
lost on every revenue dollar
Operating margin Net margin
FY2024 · Operating -29.1% · Net -30.3%
20%40%-20%-40%-60%20102012201420162018202020222024
ROE
FY2024 · ROE -51.8%
-50%-100%-150%20102012201420162018202020222024

Each USD of equity lost 52 cents this year.

Cash & shareholders
returned in FY2024 · dividends + net buybacks
Free cash flow $M
FY2024 · FCF -3.8
-2M20102012201420162018202020222024

Total assetsUSD 19.8M
EquityUSD 12.3M
CashUSD 1.8M
Gross debtUSD 1.9M
Net debtUSD 93,368.00
Current ratio1.64×

Net debt stands at 1% of equity.

The 15-year record
15 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0·
EPS, diluted $−0.85−0.49−0.03−0.18−0.01−0.11−0.05−0.04−0.12−0.15−0.19−0.26−0.510.78−1.06
Dividend / sh $···············
Payout %···············
ROE %−51.8−26.7−1.4−15.0−3.3−46.4−31.2−62.6−175.7−165.0−167.5−94.7−160.4··
Shares out B0.010.010.010.010.010.010.010.010.010.010.010.000.000.000.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 75 reconciliationsAUDITED

Reconciled in 15 of 19 fiscal years. 20 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityElectromedical & Electrotherapeutic Apparatus
Listed onNASDAQ
Incorporated inMassachusetts
Fiscal year endsJune 30
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image